Notably, the tumor cells underwent progressive phenotypic changes, including loss of estrogen receptor expression, downregulation of membrane E-cadherin, loss of polarity, and increased angiogenic potential—all consistent with tumor progression in vivo. Here, CDH1 is linked to neoplasm.